Latisse for Longer, Fuller Eyelashes: Product may Benefit those with Lash Loss Due to Disease
Latisse is a Federal Drug Administration (FDA) approved drug used for the sole purpose of promoting longer, fuller, and darker eyelashes. The main ingredient in Latisse, bimatoprost, is also in Lumigan, a prescription eye drop used by glaucoma patients to reduce the pressure in the eye. Once doctors saw that Lumigan not only worked for glaucoma but also gave their patients luxurious eyelashes, the makers of the drug quickly lowered the dose of bimatoprost in the product, tested it and then repackaged it as Latisse for lashes. It is somehow helpful for Eyelash Extension in Brisbane. Who knew having glaucoma could result in beautiful eyes?
Latisse is a prescription only medication that currently is considered for cosmetic purposes so it is not generally covered by medical insurance. Before a person can obtain a prescription it must be verified that their eyes are healthy and they are not already using a medication for glaucoma or any other eye disease. According to the clinical trials for FDA approval on 278 adults, 78 percent of the participants saw significant change in their eyelashes. Trials showed that Latisse improved eyelash length by 25 percent, fullness and thickness by 106 percent and increased eyelash darkness by 18 percent.
Latisse is a liquid drop that is applied to the base of the eyelashes each night. Results are generally noticed within 8 weeks and full results show between 12 and 16 weeks. Once full results are met, the doctor will usually have the patient lower use of Latisse to every two days or twice a week. If the person discontinues use of Latisse, then the eyelashes will eventually return to their natural state. The cost of Latisse is around $120 for 60 days of the medicine.
Side-Effects of Latisse
Common side-effects during the FDA trials were redness in the eye, itching, red, sore eyelids if the medication comes in contact with them and a brown discoloration of the skin around the eye if the medication has come in contact with it. The brown discoloration will fade if use of Latisse is discontinued. Irises can experience a color change to brown although no one in the clinical trials experienced this. However, the medication in Latisse, bimatoprost, has been known to cause changes in eye color for glaucoma patients. This side-effect is permanent. Latisse may also cause a minor decrease in pressure in the eye if the drops come in contact with it. Latisse should not be used by people who are already on medication for any eye disorder, patients who have had cataract surgery or people who have had an artificial lens implanted into their eye. Latisse should also not be used by women who are pregnant or nursing or young children.
People Who Could Benefit the Most from Latisse
Although Latisse is basically for cosmetic purposes, it may actually be beneficial to people who have lost their eyelashes due to medical issues. Cancer patients who have lost their eyelashes from chemotherapy as well as anyone who has an autoimmune disease and experiences loss of eyelashes, or people with alopecia, an abnormality in the immune system which can cause hair loss, may benefit from this drug. However, in the case of chemotherapy, doctors believe it is best to wait until the patient has completed the therapy before using Latisse since it is not yet known how the drugs will react together.
For those who have lost their eyelashes through a medical condition, however, Latisse may be just the lift in spirits they need. One woman gave Latisse a glowing review on the medical discussion site RealSelf.com after having success with it after chemotherapy. Even though this drug can be used by anyone to obtain long, thick beautiful lashes, it is reassuring to know that it can be used by people who have had medical setbacks and can really use the self-esteem lift this product gives.